Filing Details

Accession Number:
0000899243-21-022990
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-10 17:01:34
Reporting Period:
2021-06-09
Accepted Time:
2021-06-10 17:01:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1703057 Abcellera Biologics Inc. ABCL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834418 Veronique Lecault C/O Abcellera Biologics Inc.
2215 Yukon Street
Vancouver A1 V5Y 0A1
Chief Operating Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2021-06-09 1,000,000 $25.50 273,630 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 1,006,000 Direct
Common Shares 61,580 Indirect By spouse
Common Shares 7,155,008 Indirect See Footnote
Footnotes
  1. On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
  2. The sale of the shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act"), to the extent of 23,000 shares, with the purchase by the Reporting Person of 6,000 shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 17,000 shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act.
  3. These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
  4. These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.